Saratov JOURNAL of Medical and Scientific Research

Modern strategy of diagnostics and treatment of NSAID-induced enteropathy in elderly

Year: 2015, volume 11 Issue: №1 Pages: 052-056
Heading: Gerontology and geriatrics Article type: Original article
Authors: Lipatova Т.Е., Dudaeva N.G.
Organization: Saratov State Medical University

The aim of the research is to improve the efficiency of diagnosis and treatment of NSAID-induced enteropathy at elderly patients with chronic pain (osteoarthritis, dorsopathy). Material and Methods. 300 elderly with osteoarthritis or dorsopathies regularly (8 weeks or more) receiving diclofenac at 75 mg per day were inspected. Clinical features, morphology, components of the diffuse endocrine system of the small intestine were studied. Results. It is defined, that at elderly patients with regular use of NSAIDs in 25% of cases postbulbar erosive duodenitis, in 75% of cases inflammatory and atrophic changes of the distal duodenum were diagnosed. Diagnosis of NSAID-induced enteropathy at elderly should include faecal calprotectin and morphology analysis of postbulbar area of the duodenum. Use meloxicam and sulfasalazine at older patients helps to eliminate or reduce intestinal dyspepsia, malabsorption, and intestinal inflammation on the results of faecal calprotectin and of histology of the small intestine. Conclusion. Elderly patients are at high-risk group for NSAID-induced enteropathy due to functional disturbances in the neuroendocrine system of the small intestine.

1. Vakhrushev YaM, Zagrebina EA. Enteropathy induced by nonsteroidal anti-inflammatory drugs (pathogenesis, diagnosis, treatment). Ter Arkh 2012; (5): 74-79
2. Smale S, Tibbie J, Sigthorsson G, et al. Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Pract Res Clin Gastroenterol 2001; 15 (5): 732-738
3. Morris AJ, Madhok R, Sturrock RD, et al. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroi-dal antiinflammatory drugs. Lancet 1991; 337 (8740): 520
4. Laine L, Connors LG, Reicin A, et al. Serious lower gastrointestinal clinical events with nonselective NSAID orcoxib use. Gastroenterology 2003; 124 (2): 288-292
5. Lim YJ, Chun HJ. Recent Advances in NSAIDs-lnduced Enteropathy Therapeutics: New Options, New Challenges. Gastroenterol Res Pract 2013; Article ID 761060
6. Tibbie JA, Bjarnason I. Faecal calprotectin as an index of intestinal inflammation. Drugs of Today 2001; 37: 85-96
7. Maiden L, Thjodleifsson B, TheodorsA, et al. A quantitative analysis of NSAID-induced small bowel pathology by capsule en-teroscopy. Gastroenterology 2005; 128 (5): 1172-1178
8. Parfenov Al. Enterology. M.: Triada-X, 2002; 744 p.
9. Shah V, Lyford G, Gores G, et al. Nitric oxide in gastrointestinal health and disease. Gastroenterology 2004; 126 (3): 903-913
10. Slomiany BL, Piotrowski J, Slomiany A. Endothelin-1, interleukin-4 and nitric oxide synthase modulators of gastric mu-cosal injury by indomethacin: effect of antiulcer agents. J Physiol Pharmacol 1999; 50 (2): 197-210.

2015_01_052-056.pdf427.11 KB

No votes yet